Abstract

Lower respiratory tract infections (LRTIs) represent a diverse spectrum of diseases that continue to pose a substantial burden on healthcare systems globally. This article delves into the dynamic landscape of LRTI treatments, exploring both innovations and persistent hurdles in managing these infections. While innovations in LRTI treatments, including antibiotic stewardship, advanced diagnostics, and vaccination programs, have offered promising solutions, challenges such as antibiotic resistance, viral LRTIs, resource disparities, and patient adherence remain formidable obstacles. A holistic understanding of the ongoing advancements and challenges in LRTI treatments is crucial for improving patient outcomes and shaping future research and healthcare strategies.